Location History:
- Xizhi, TW (2012 - 2013)
- New Taipei, TW (2016)
Company Filing History:
3 out of 16 
1 out of 96 
1 out of 685 
Years Active: 2012-2016
Title: Woan-Eng Chan: Innovator in Antibody Therapeutics
Introduction
Woan-Eng Chan is a distinguished inventor based in Xizhi, Taiwan, known for his innovative contributions in the field of antibody therapeutics. With a focus on developing treatments targeting various immune response disorders and viral infections, Chan has secured three patents that highlight his expertise and dedication to advancing medical science.
Latest Patents
Woan-Eng Chan's recent patents include significant developments in anti-granulysin antibodies and anti-herpes simplex virus antibodies. His first patent, titled "Anti-granulysin antibodies and methods of use thereof," describes an anti-granulysin antibody capable of neutralizing granulysin activity and includes specific sequences that can effectively treat unwanted immune response disorders such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), or graft-versus-host disease (GVHD). His second patent, "Anti-herpes simplex virus antibodies and methods of use thereof," details antibodies and polypeptides that directly target the glycoprotein D of the herpes simplex virus (HSV), providing a pathway for diagnosing and treating HSV infections.
Career Highlights
Throughout his career, Woan-Eng Chan has been affiliated with notable organizations, including DCB-USA LLC and the Development Center for Biotechnology. His experiences at these institutions have greatly contributed to his knowledge and skills in biotechnology and antibody research.
Collaborations
Chan has collaborated with accomplished professionals in the field, including Jiann-Shiun Lai and Hung-Ling Wang, enhancing his research and innovation through shared expertise and teamwork.
Conclusion
Woan-Eng Chan stands out as a pivotal figure in antibody innovation, with his impactful patents demonstrating a commitment to improving healthcare outcomes. His work not only furthers scientific understanding but also offers hope for effective treatments for serious immune disorders and viral infections. His continuous contributions to the field promise to inspire future advancements in biotechnology.